阿克拉霉素(Aclacinomycin.ACM)为第二代蒽环类新型抗肿瘤抗生素。日本安禾霉素协作研究组374例报告,其主要副作用的发生率为:恶心呕吐35.8～43.6%、贫血(<12g)、血小板减少(<7×10~4)、白细胞减少(<4×10~3)各为9.5%、22.2%、29.7%,ECG改变6.1%,肝损害4.5%,静脉炎和口腔炎 Aclacinomycin (AClacinomycin.ACM) is a new generation of anthracycline antitumor antibiotics. 374 cases reported in the collaborative research group of chloramphenicol in Japan. The main side effects were as follows: nausea and vomiting 35.8-43.6%, anemia (<12g), thrombocytopenia (<7x10-4), leucopenia 10 to 3) were 9.5%, 22.2%, 29.7%, ECG changes 6.1%, liver damage 4.5%, phlebitis and stomatitis